CytoDyn Inc. (CYDY: OTCQB) | FDA Grants Rolling Review for

Mar 4, 2019 at 6:45 AM 52

CytoDyn Inc. (CYDY: OTCQB) | FDA Grants Rolling Review for CytoDyn’s Planned BLA for Investigational HIV Therapy Leronlimab (PRO 140)

Newer

Older